Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.

Jonas GrafMarius RingelsteinKlaudia LepkaJörg SchallerHelmut QuackHans-Peter HartungOrhan AktasPhilipp Albrecht

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2018)

Our case highlights the profound effect of alemtuzumab on the immune system and its possible risk for autoimmune complications.

Keyphrases